Doctor checking with depressor sore throat to teenage girl

(© Alexander Raths - stock.adobe.com)


Study author: ‘We could be looking at a worldwide public health infectious disease problem.’


HOUSTON — The bacteria responsible for a number of illnesses in humans including strep throat and necrotizing fasciitis (flesh eating disease) appears to be becoming less and less vulnerable to frequently used antibiotics. These concerning findings indicate that Group A streptococcus may soon become completely resistant to penicillin and other antibiotics of the like, also known as beta-lactams.

“If this germ becomes truly resistant to these antibiotics, it would have a very serious impact on millions of children around the world. That is a very concerning but plausible notion based on our findings. Development of resistance to beta-lactam antibiotics would have a major public health impact globally,” comments lead study author Dr. James M. Musser, chair of the Department of Pathology and Genomic Medicine at Houston Methodist Hospital, in a release.

These findings are the culmination of an exhaustive international effort spanning close to a dozen institutions spread across seven nations.

The research team at Houston Methodist Hospital closely analyzed their entire available genome sequence library derived from 7,025 group A streptococcus strains that had been collected over a number of years and from multiple countries. Among that group, they noted 2% with concerning gene mutations. Those mutated strains were then subjected to further testing in a clinical microbiology laboratory. The additional tests confirmed that the strains in questions indeed displayed a lower vulnerability to beta-lactam antibiotics.

Scientists have believed for years that group A streptococcus lacked the necessary gene mutations to develop a resistance to penicillin, but these new findings paint very different and much more concerning picture. Now it seems penicillin and other antibiotic treatments for strep throat and flesh eating disease cases caused by this bacteria may one day be rendered totally useless. According to the study’s authors, their results only strengthen the urgent need for the development of a group A streptococcus vaccine.

“We could be looking at a worldwide public health infectious disease problem,” Musser comments. “When strep throat doesn’t respond to frontline antibiotics such as penicillin, physicians must start prescribing second-line therapies, which may not be as effective against this organism.”

Based on CDC figures, group A streptococcus is currently responsible for about 20-30% of sore throats seen in children, and 15% of adult sore throats.

Researchers say their next moves involve conducting a series of experiments in hopes of understanding how these mutated strains may manifest themselves in human carriers.

The study is published in the Journal of Clinical Microbiology.

About John Anderer

Born blue in the face, John has been writing professionally for over a decade and covering the latest scientific research for StudyFinds since 2019. His work has been featured by Business Insider, Eat This Not That!, MSN, Ladders, and Yahoo!

Studies and abstracts can be confusing and awkwardly worded. He prides himself on making such content easy to read, understand, and apply to one’s everyday life.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

Chris Melore

Editor

Sophia Naughton

Associate Editor